Studies have also shown that treatment with mixed tocopherols and tocotrienols, reduced COX-2 expression [21], and combined treatment of γ-tocotrienol with the specific COX-2 inhibitor, celecoxib, resulted in a synergistic inhibition in mammary tumor cell growth [22, 23]. This evidence concerns the gene PTGS2 and breast cancer.